Germany· DE-A57-7e1ebfc31b0a9d12
Indigocarmin Provingo
A indigo carmine product containing indigo carmine, registered in Germany by Provepharm Sas. The same ATC class is registered in 10 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Indigo carmine is registered in 10 of 19 countries.
Countries holding a registration under ATC V04CH02 (indigo carmine), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 5 of them publish a price we can compare per daily dose
Indigo carmine · ATC V04CH02
10 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Germany
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Indigo Carmine
- Manufacturer
- Provepharm Sas
- Country
- Germany (DE)
- ATC code
- V04CH02
- ATC class
- Indigo carmine
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 23, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Indigo carmine in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBlumyne 40mg/5ml solution for injection ampoulesProvepharm UK Ltd
- United StatesBludigoSagent Pharmaceuticals
- NetherlandsIndigokarmijn Provingo 40 mg/5 ml, oplossing voor injectieProvepharm SAS
- BelgiumCarmin d’Indigo Serb 40 mg/5 mlSERB
- FinlandCarmyneSERB S.A.
- SpainPROVINGO 40 MG/5 ML SOLUCION INYECTABLEProvepharm
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/712a3c94-9413-4525-a6a5-8ec1b6381cae GET /v1/drugs/712a3c94-9413-4525-a6a5-8ec1b6381cae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Indigo Carmine",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about indigo carmine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.